Fuller & Thaler Asset Management Inc. Boosts Stock Holdings in Doximity, Inc. $DOCS

Key Points

• Fuller & Thaler Asset Management Inc. raised its stake in Doximity, Inc. by 9.5%, owning approximately 1.73 million shares worth $100.4 million as of the latest SEC filing.
• Doximity's shares have seen significant interest from investors, with hedge funds and other institutional investors owning about 87.19% of the company's stock.
• The company reported $0.36 earnings per share for its latest quarter, surpassing analysts' expectations by $0.05 and marking a 15.2% revenue increase year-over-year.

Fuller & Thaler Asset Management Inc. grew its holdings in Doximity, Inc. (NASDAQ:DOCS - Free Report) by 9.5% during the 1st quarter, according to the company in its most recent filing with the SEC. The fund owned 1,730,282 shares of the company's stock after purchasing an additional 150,574 shares during the period. Fuller & Thaler Asset Management Inc. owned approximately 0.93% of Doximity worth $100,408,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently modified their holdings of DOCS. Vanguard Group Inc. grew its position in Doximity by 8.8% during the 1st quarter. Vanguard Group Inc. now owns 12,194,492 shares of the company's stock worth $707,646,000 after acquiring an additional 990,923 shares during the last quarter. Invesco Ltd. grew its position in Doximity by 54.8% during the 1st quarter. Invesco Ltd. now owns 1,969,326 shares of the company's stock worth $114,280,000 after acquiring an additional 696,923 shares during the last quarter. Dimensional Fund Advisors LP grew its position in Doximity by 4.2% during the 4th quarter. Dimensional Fund Advisors LP now owns 1,576,455 shares of the company's stock worth $84,167,000 after acquiring an additional 63,815 shares during the last quarter. Northern Trust Corp grew its position in Doximity by 9.4% during the 4th quarter. Northern Trust Corp now owns 1,459,185 shares of the company's stock worth $77,906,000 after acquiring an additional 125,332 shares during the last quarter. Finally, Bank of New York Mellon Corp grew its position in Doximity by 8.2% during the 1st quarter. Bank of New York Mellon Corp now owns 1,137,912 shares of the company's stock worth $66,033,000 after acquiring an additional 86,135 shares during the last quarter. Institutional investors own 87.19% of the company's stock.

Insider Activity

In related news, Director Timothy S. Cabral sold 10,000 shares of the firm's stock in a transaction dated Wednesday, June 25th. The shares were sold at an average price of $60.00, for a total transaction of $600,000.00. Following the transaction, the director directly owned 6,360 shares of the company's stock, valued at $381,600. This trade represents a 61.12% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Director Kira Scherer Wampler sold 2,000 shares of Doximity stock in a transaction that occurred on Friday, August 1st. The stock was sold at an average price of $57.09, for a total transaction of $114,180.00. Following the transaction, the director directly owned 16,618 shares in the company, valued at approximately $948,721.62. This represents a 10.74% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 36,000 shares of company stock worth $2,140,940 over the last quarter. Insiders own 31.30% of the company's stock.

Doximity Trading Down 0.4%

DOCS stock traded down $0.2830 during trading on Thursday, reaching $64.0770. 942,349 shares of the stock were exchanged, compared to its average volume of 2,327,430. The firm's 50 day moving average is $60.42 and its 200 day moving average is $60.37. The firm has a market cap of $12.00 billion, a P/E ratio of 64.08, a price-to-earnings-growth ratio of 4.10 and a beta of 1.36. Doximity, Inc. has a twelve month low of $35.32 and a twelve month high of $85.21.

Doximity (NASDAQ:DOCS - Get Free Report) last posted its earnings results on Thursday, August 7th. The company reported $0.36 earnings per share for the quarter, beating analysts' consensus estimates of $0.31 by $0.05. Doximity had a return on equity of 21.75% and a net margin of 36.60%.During the same period last year, the firm earned $0.28 EPS. The firm's quarterly revenue was up 15.2% compared to the same quarter last year. Doximity has set its FY 2026 guidance at EPS. Q2 2026 guidance at EPS. As a group, analysts predict that Doximity, Inc. will post 0.99 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

A number of brokerages have recently commented on DOCS. BTIG Research upgraded shares of Doximity from a "neutral" rating to a "buy" rating and set a $80.00 price target on the stock in a report on Monday, June 2nd. Morgan Stanley lowered their target price on Doximity from $71.00 to $60.00 and set an "equal weight" rating for the company in a research report on Thursday, April 24th. Bank of America upped their price target on Doximity from $55.00 to $62.00 and gave the company a "neutral" rating in a research report on Wednesday, June 25th. Truist Financial increased their price target on Doximity from $52.00 to $61.00 and gave the company a "hold" rating in a research note on Thursday, July 17th. Finally, Wells Fargo & Company lifted their target price on shares of Doximity from $55.00 to $62.00 and gave the stock an "equal weight" rating in a research note on Monday, August 4th. Two analysts have rated the stock with a Strong Buy rating, ten have issued a Buy rating and ten have assigned a Hold rating to the company. According to MarketBeat, Doximity has a consensus rating of "Moderate Buy" and an average target price of $66.21.

Doximity Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.